Literature DB >> 24468158

Improving the care of high-risk patients: the potential of PCSK9.

Jane Stock1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24468158     DOI: 10.1016/j.atherosclerosis.2013.11.050

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Authors:  G M Anantharamaiah; Dennis Goldberg
Journal:  Clin Lipidol       Date:  2015-01-01

2.  Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population.

Authors:  Wen Guo; Yingyun Gong; Yong Gu; Zhenzhen Fu; Hongqi Fan; Beibei Gao; Xiaohui Zhu; Jinxiang Fu; Yang Zhao; Min Sun; Xing Liu; Xian-Cheng Jiang; Tao Yang; Hongwen Zhou
Journal:  Lipids Health Dis       Date:  2018-01-17       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.